DK0704219T3 - Anvendelse af faktor for osteoblastisk celledeling - Google Patents

Anvendelse af faktor for osteoblastisk celledeling

Info

Publication number
DK0704219T3
DK0704219T3 DK95111224T DK95111224T DK0704219T3 DK 0704219 T3 DK0704219 T3 DK 0704219T3 DK 95111224 T DK95111224 T DK 95111224T DK 95111224 T DK95111224 T DK 95111224T DK 0704219 T3 DK0704219 T3 DK 0704219T3
Authority
DK
Denmark
Prior art keywords
factor
cell division
osteoblastic cell
bone
diseaese
Prior art date
Application number
DK95111224T
Other languages
Danish (da)
English (en)
Inventor
Akira Kudo
Tohru Nakanishi
Masaharu Takigawa
Original Assignee
Aventis Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Ltd filed Critical Aventis Pharma Ltd
Application granted granted Critical
Publication of DK0704219T3 publication Critical patent/DK0704219T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK95111224T 1994-07-22 1995-07-18 Anvendelse af faktor for osteoblastisk celledeling DK0704219T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20125794A JP3738281B2 (ja) 1994-07-22 1994-07-22 新規な骨芽細胞増殖因子

Publications (1)

Publication Number Publication Date
DK0704219T3 true DK0704219T3 (da) 2002-02-04

Family

ID=16437950

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95111224T DK0704219T3 (da) 1994-07-22 1995-07-18 Anvendelse af faktor for osteoblastisk celledeling

Country Status (14)

Country Link
US (1) US6080720A (fr)
EP (1) EP0704219B1 (fr)
JP (1) JP3738281B2 (fr)
KR (1) KR100361717B1 (fr)
AT (1) ATE206930T1 (fr)
AU (1) AU693567B2 (fr)
CA (1) CA2154403A1 (fr)
DE (1) DE69523250T2 (fr)
DK (1) DK0704219T3 (fr)
ES (1) ES2161809T3 (fr)
FI (1) FI953514A7 (fr)
HU (1) HU217082B (fr)
NO (1) NO952912L (fr)
PT (1) PT704219E (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012017535A2 (pt) 2010-01-15 2019-09-24 Of Medicine And Dentistry Of New Jersey University uso de compostos de vanádio para cicatrização de osso
JP5992917B2 (ja) 2010-12-10 2016-09-14 ユニバーシティ オブ メディスン アンド デンティストリー オブ ニュー ジャージー インスリン疑似剤コンポジットで被覆される埋め込み型デバイスおよびその方法
US20140322292A1 (en) 2010-12-10 2014-10-30 Rutgers, The State University Of New Jersey Insulin-mimetics as therapeutic adjuncts for bone regeneration
US9931348B2 (en) 2011-07-06 2018-04-03 Rutgers, The State University Of New Jersey Vanadium compounds as therapeutic adjuncts for cartilage injury and repair

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1000980B (el) * 1989-08-30 1993-03-31 Max Planck Gesellschaft Νευροτροφινη-3,ενας νεος neυροτροφικος παραγοντας που σχετιζεται με τον παραγοντα αναπτυξης νευρων και τον νευροτροφικο παραγοντα που προερχεται απο τον εγκεφαλο.
AU2460595A (en) * 1994-05-06 1995-11-29 Regeneron Pharmaceuticals, Inc. Methods based on the role of neurotrophin 3 in female reproduction

Also Published As

Publication number Publication date
DE69523250T2 (de) 2002-07-04
AU693567B2 (en) 1998-07-02
EP0704219A3 (fr) 1997-12-10
AU2710595A (en) 1996-02-01
HUT73185A (en) 1996-06-28
JP3738281B2 (ja) 2006-01-25
JPH0834744A (ja) 1996-02-06
ATE206930T1 (de) 2001-11-15
US6080720A (en) 2000-06-27
KR960003741A (ko) 1996-02-23
FI953514A0 (fi) 1995-07-20
EP0704219A2 (fr) 1996-04-03
HU9502202D0 (en) 1995-09-28
NO952912D0 (no) 1995-07-21
PT704219E (pt) 2002-03-28
HU217082B (hu) 1999-11-29
DE69523250D1 (de) 2001-11-22
FI953514L (fi) 1996-01-23
KR100361717B1 (ko) 2003-07-07
ES2161809T3 (es) 2001-12-16
FI953514A7 (fi) 1996-01-23
EP0704219B1 (fr) 2001-10-17
NO952912L (no) 1996-01-23
CA2154403A1 (fr) 1996-01-23

Similar Documents

Publication Publication Date Title
DE69825292D1 (de) Verwendung von inosine zur herstellung eines medikamentes zur stimulierung des axonwachstums von zns-neuronen
HUT77380A (hu) Kombinált gyógyszerkészítmény alkalmazása sclerosis multiplex (MS) és más demielizáló állapotok kezelésére
UA29505C2 (uk) Фармацевтична композиція для лікування і/або профілактики розрідження кістки і спосіб лікування і/або профілактики розрідження кістки у ссавців
CY2007001I2 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
IL114683A0 (en) Combination treatment for inhibiting bone loss
DK0668763T3 (da) Anvendelse af phenserin til fremstillingen af lægemidler til behandlingen af kognitive sygdomme
ATE184788T1 (de) Idebenone-haltige zusammensetzungen zur behandlung von m. alzheimer
NO930715L (no) Nerve-implantert system
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
DE69426530D1 (de) Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz
BR9710250A (pt) Composto composição farmacêutica e processos para tratar uma infecção bacteriana em um paciente em necessidade de tal tratamento e para produzir um composto de bromotiacumicina
DK0704219T3 (da) Anvendelse af faktor for osteoblastisk celledeling
DE69920418D1 (de) Arzneimittel gegen hepatitis
DE69314586D1 (de) Arzneimittelzusammensetzung enthaltend TCF-II
IT1276706B1 (it) Bicarbonati di derivati della 2,6-dimetilanilina, loro uso in terapia e composizioni farmaceutiche che li comprendono
NO20010984D0 (no) Anvendelse av R(+)-<alfa>-(2,3-dimetoksyfenyl)-1-[2-(4- fluorfenyl)etyl]-4-piperidinmetanol for behandling av søvnforstyrrelser
SU1833719A1 (ru) Cпocoб xиpуpгичeckoгo лeчehия cпиhhomoзгoboй гpыжи, coчetaющeйcя c гидpoцeфaлиeй
IT1262567B (it) Pirrolidin-2-oni,loro preparazione,composizioni farmaceutiche che li contengono e loro uso in terapia.
IL103499A0 (en) Pharmaceutical compositions for treating anxiety in benzodiazepine withdrawn patients
AU5699690A (en) Laser apparatus for treating bone and tooth tissue
PL54844Y1 (en) Dental surgeon's syringe
DE59405654D1 (de) T-lymphozyten enthaltende pharmazeutische zusammensetzung zur behandlung von infektionen
MX9707735A (es) Nuevo uso de (s)-adenosil-l-metionina (same).
ITBO930473A0 (it) Dispositivo per la realizzazione di protesi dentarie da implantologia